-
Hot News: Hewlett-Packard Company (NYSE:HPQ), RF Micro Devices Inc. (NASDAQ:RFMD), LyondellBasell Industries N.V. (NYSE:LYB), Ocera Therapeutics (NASDAQ:OCRX), Kinross Gold Corporation (NYSE:KGC)
Hewlett-Packard Company (NYSE:HPQ) EVP Michael G. Nefkens sold 19,000 shares of the stock in a transaction dated Wednesday, December 3rd. The shares were sold at an average price of $38.78, for a total value of $736,820.00. Following the completion of the transaction, the executive vice president now directly owns 9,054 shares of the company’s stock,…
-
Stock Highlights: Auspex Pharmaceuticals (NASDAQ:ASPX), Nokia Corporation (NYSE:NOK), Ocera Therapeutics (NASDAQ:OCRX), American Apparel (NYSEMKT: APP), Stein Mart Inc. (NASDAQ:SMRT)
On 10 November Auspex Pharmaceuticals, Inc. (NASDAQ:ASPX) reported recent business highlights and announced its financial results for the three and nine months ended September 30, 2014. For the three months ended September 30, 2014, Auspex reported a net loss of $19.0 million, an increase of $16.2 million from the $2.8 million reported for the comparable…
-
Biotech Bears in Focus: Avalanche Biotechnologies (NASDAQ:AAVL), Ocera Therapeutics (NASDAQ:OCRX), Ocular Therapeutix (NASDAQ:OCUL), Macrocure (NASDAQ:MCUR), Affimed N.V. (NASDAQ:AFMD)
Avalanche Biotechnologies, Inc. (NASDAQ:AAVL) on 12 November reported General and administrative (G&A) expenses were $2.4 million for the quarter ended September 30, 2014, compared to $0.3 million for the quarter ended September 30, 2013. Net loss attributable to common stockholders was $8.3 million for the quarter ended September 30, 2014, compared to a net loss…
-
Biotech Stocks Unusual Volume: XOMA Corporation (NASDAQ:XOMA), Incyte Corporation (NASDAQ:INCY), Jazz Pharmaceuticals (NASDAQ:JAZZ), Ocera Therapeutics (NASDAQ:OCRX), Medgenics (NYSEMKT:MDGN)
XOMA Corporation (NASDAQ:XOMA) on Nov. 6 reported a loss of $14.4 million in its third quarter. On a per-share basis, the company said it had a loss of 17 cents. Losses, adjusted for non-recurring gains, came to 20 cents per share. The results missed Wall Street expectations. The average estimate of analysts was for a…
-
Today’s Stocks: Geron Corporation (NASDAQ:GERN), The Procter & Gamble Company (NYSE:PG), Ocera Therapeutics (NASDAQ:OCRX), Watts Water Technologies (NYSE:WTS), Dunkin’ Brands (NASDAQ:DNKN)
On 13 November Geron Corporation (NASDAQ:GERN) announced that the company has entered into an exclusive worldwide license and collaboration agreement with Janssen Biotech, Inc. (“Janssen”) to develop and commercialize, imetelstat, Geron’s telomerase inhibitor product candidate, for oncology, including hematologic malignancies, and other human therapeutics uses. Imetelstat is a modified oligonucleotide that is currently in early…